GENERAC HOLDINGS INC.·4

Mar 3, 6:55 PM ET

MINICK RUSSELL S 4

4 · GENERAC HOLDINGS INC. · Filed Mar 3, 2021

Insider Transaction Report

Form 4
Period: 2021-03-01
MINICK RUSSELL S
Executive Vice President Sales
Transactions
  • Award

    Common Stock

    2021-03-01+5,36813,136 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$52.06/sh+5,788$301,35220,980 total
  • Sale

    Common Stock

    2021-03-01$335.00/sh5,740$1,922,90015,240 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$102.42/sh+2,360$241,69917,552 total
  • Sale

    Common Stock

    2021-03-03$338.45/sh894$302,57614,298 total
  • Sale

    Common Stock

    2021-03-03$335.42/sh3,820$1,281,2959,117 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-03-016,2390 total
    Exercise: $40.12Exp: 2027-03-01Common Stock (6,239 underlying)
  • Award

    Common Stock

    2021-03-01+99214,128 total
  • Sale

    Common Stock

    2021-03-01$335.00/sh6,239$2,090,06515,192 total
  • Sale

    Common Stock

    2021-03-01$335.00/sh6,088$2,039,48015,192 total
  • Sale

    Common Stock

    2021-03-03$337.10/sh586$197,54112,937 total
  • Tax Payment

    Common Stock

    2021-03-01$335.91/sh1,913$642,59612,215 total
  • Award

    Common Stock

    2021-03-01+2,97715,192 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$40.12/sh+6,239$250,30921,431 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$43.88/sh+6,088$267,14121,280 total
  • Sale

    Common Stock

    2021-03-01$336.29/sh48$16,14215,192 total
  • Sale

    Common Stock

    2021-03-01$335.00/sh2,360$790,60015,192 total
  • Sale

    Common Stock

    2021-03-03$338.65/sh775$262,45713,523 total
  • Sale

    Common Stock

    2021-03-03$336.87/sh1,548$521,4767,569 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-03-016,0886,088 total
    Exercise: $43.88Exp: 2028-03-01Common Stock (6,088 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-03-015,78811,576 total
    Exercise: $52.06Exp: 2029-03-01Common Stock (5,788 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-03-012,3607,081 total
    Exercise: $102.42Exp: 2030-03-01Common Stock (2,360 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-03-01+2,7182,718 total
    Exercise: $335.91Exp: 2031-03-01Common Stock (2,718 underlying)
Footnotes (9)
  • [F1]Subject to continued service through the vesting date, the Restricted Shares shall all vest in equal installments on each of the first three (3) anniversaries of the Date of Grant.
  • [F2]Subject to continued service through the vesting date, the Restricted Shares shall vest in full on the third anniversary of the Date of Grant.
  • [F3]The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021.
  • [F4]The price reported is the weighted average price. The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021. The shares were sold in multiple transactions at prices ranging from $338.39 to $338.64, inclusive. The reporting person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  • [F5]The price reported is the weighted average price. The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021. The shares were sold in multiple transactions at prices ranging from $338.48 to $339.22, inclusive. The reporting person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  • [F6]The price reported is the weighted average price. The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021. The shares were sold in multiple transactions at prices ranging from $335.23 to $335.98, inclusive. The reporting person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  • [F7]The price reported is the weighted average price. The shares were sold pursuant to the terms of a trading plan under Rule 10b5-1 previously entered into on February 25, 2021. The shares were sold in multiple transactions at prices ranging from $336.44 to $337.17, inclusive. The reporting person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  • [F8]Subject to continued service through the vesting date, the Options shall all vest in equal installments on each of the first four (4) anniversaries of the Date of Grant.
  • [F9]Subject to continued service through the vesting date, the Options vested in equal installments on each of the first four (4) anniversaries of the Date of Grant.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4